---

Although HIV-1 has been the most studied infectious agent in the last 30 years and Its widely believed that induction of neutralizing antibodies were sufficient for the protection against HIV . A novel mode of action of HIV infection assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protection against destruction by the cytotoxic CD8+ T-cells. This postulation differs from the ordinary rationales that depend on the role of neutralizing antibodies in controlling the HIV infection. In This book we introduce V20E as a new therapeutic immune peptides modality with a highly promising cure for HIV-1 disease and human immunodeficiency syndrome.

---

Dr. Sherif Salah is a Consultant of immunology,vet. Medicine Cairo University Holds a Ph. D.degree inimmunology, Innovator of three Pharmaceuticals inMarkets, published many articles and books in HIV,cancer andParkinson´s & Alzheimer´s journals and awarded fourpatents of invention on novel Biological molecules for treatment of HCV and HIV.

---